Charles M. Perou
Gründer bei GeneCentric Therapeutics, Inc.
Aktive Positionen von Charles M. Perou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - | - |
| Gründer | 01.01.2011 | - | |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | 01.01.2000 | - |
Karriereverlauf von Charles M. Perou
Ausbildung von Charles M. Perou
| Bates College | Undergraduate Degree |
| University of Utah | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Charles M. Perou
- Erfahrung
